Abstract
This guidance for the management of patients with hymenoptera venom allergy has been prepared by the Standards of Care Committee (SOCC) of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well as on expert opinion and is for use by both adult physicians and pediatricians practising allergy. During the development of these guidelines, all BSACI members were included in the consultation process using a web-based system. Their comments and suggestions were carefully considered by the SOCC. Where evidence was lacking, consensus was reached by the experts on the committee. Included in this guideline are epidemiology, risk factors, clinical features, diagnostic tests, natural history of hymenoptera venom allergy and guidance on undertaking venom immunotherapy (VIT). There are also separate sections on children, elevated baseline tryptase and mastocytosis and mechanisms underlying VIT. Finally, we have made recommendations for potential areas of future research.
| Original language | English |
|---|---|
| Pages (from-to) | 1201-1220 |
| Number of pages | 20 |
| Journal | Clinical and Experimental Allergy |
| Volume | 41 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - Sept 2011 |
Keywords
- ACE inhibitor
- anaphylaxis
- baseline tryptase
- bee
- beta-blocker
- hornet
- hymenoptera
- IgE
- immunotherapy
- venom
- wasp
- YELLOW JACKET VENOM
- INSECT STING ALLERGY
- INDOLENT SYSTEMIC MASTOCYTOSIS
- CONVERTING ENZYME-INHIBITORS
- ANTIGENIC CROSS-REACTIVITY
- PLACEBO-CONTROLLED TRIAL
- BASOPHIL ACTIVATION TEST
- LARGE LOCAL REACTIONS
- BASAL SERUM TRYPTASE
- WASP VENOM